Astec Lifesciences (NSE:ASTEC) Cash-to-Debt : 0.01 (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Astec Lifesciences Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Astec Lifesciences's cash to debt ratio for the quarter that ended in Mar. 2024 was 0.01.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Astec Lifesciences couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Astec Lifesciences's Cash-to-Debt or its related term are showing as below:

NSE:ASTEC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0 Med: 0.01 Max: 0.14
Current: 0.01

During the past 13 years, Astec Lifesciences's highest Cash to Debt Ratio was 0.14. The lowest was 0.00. And the median was 0.01.

NSE:ASTEC's Cash-to-Debt is ranked worse than
98.76% of 241 companies
in the Agriculture industry
Industry Median: 0.66 vs NSE:ASTEC: 0.01

Astec Lifesciences Cash-to-Debt Historical Data

The historical data trend for Astec Lifesciences's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Astec Lifesciences Cash-to-Debt Chart

Astec Lifesciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Cash-to-Debt

Get a 7-Day Free Trial

0.02

0.01

Astec Lifesciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															-	N/A	0.01	N/A	0.01

Competitive Comparison of Astec Lifesciences's Cash-to-Debt

For the Agricultural Inputs subindustry, Astec Lifesciences's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astec Lifesciences's Cash-to-Debt Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Astec Lifesciences's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Astec Lifesciences's Cash-to-Debt falls into.

Astec Lifesciences Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Astec Lifesciences's Cash to Debt Ratio for the fiscal year that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	43.936	/	(2948.947	+	1990)
	=	0.01

Astec Lifesciences's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	43.936	/	(2948.947	+	1990)
	=	0.01

Astec Lifesciences (NSE:ASTEC) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Astec Lifesciences Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Astec Lifesciences's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Astec Lifesciences (NSE:ASTEC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Astec Lifesciences Ltd (NSE:ASTEC) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

533138:India

Address

Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079

Website

https://www.astecls.com

Astec Lifesciences Ltd is engaged in producing agrochemicals and pharmaceutical intermediates. The company's products include agrochemicals, such as Tebuconazole, Propiconazole, Hexaconazole, Difenoconazole, Epoxiconazole, Cyproconazole, Flutriafol, Tricyclazole, Metalaxyl and lambda-cyhalothrin, and intermediates. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.

Astec Lifesciences (NSE:ASTEC) Headlines

No Headlines